Rho/Rock cross-talks with transforming growth factor-β/Smad pathway participates in lung fibroblast-myofibroblast differentiation

Biomedical Reports

Volumn 2, Issue 6, 2014, Pages 787-792

  Ji, Hong ^a   Tang, Haiying ^a   Lin, Hongli ^a   Mao, Jingwei ^a   Gao, Lili ^a   Liu, Jia ^a   Wu, Taihua ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Myofibroblast; Pulmonary fibrosis; Rho; Rho associated coiled coil forming protein kinase; Smad; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; FIBRONECTIN; LAMININ; MESSENGER RNA; RHO FACTOR; RHO KINASE; SMAD PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG FIBROBLAST; LUNG FIBROSIS; MOLECULAR INTERACTION; MYOFIBROBLAST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPERNATANT; WESTERN BLOTTING;

EID: 85032582680     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2014.323     Document Type: Article

References (20)

1. Warburton D, Shi W and Xu B: TGF-β-Smad3 signaling in emphysema and pulmonary fibrosis: an epigenetic aberration of normal development? Am J Physiol Lung Cell Mol Physiol 304: L83-L85, 2012.
2. Antoniou KM, Margaritopoulos GA and Siafakas NM: Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future. Eur Respir Rev 22: 281-291, 2013.
3. Harris WT, Kelly DR, Zhou Y, et al: Myfibroblast differentiation and enhanced TGF-β signaling in cystic fibrosis lung disease. PLoS One 8: e70196, 2013.
4. Moriyama T and Nagatoya K: The Rho-ROCK system as a new therapeutic target for preventing interstitial fibrosis. Drug News Perspect 17: 29-34, 2004.
5. Gao HC, Zhao H, Zhang WQ, Li YQ and Ren LQ: The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models. Exp Ther Med 5: 1123-1128, 2013.
6. Liu M, Gu M, Wu Y, et al: Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats. J Surg Res 157: e117-e127, 2009.
7. Hu YB, Li X, Liang GN, Deng ZH, Jiang HY and Zhou JH: Roles of Rho/Rock signaling pathway in silica-induced epithelial-mesenchymal transition in human bronchial epithelial cells. Biomed Environ Sci 26: 571-576, 2013.
8. Tada S, Iwamoto H, Nakamuta M, et al: A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol 34: 529-536, 2001.
9. Kosanovic D, Dahal BK, Wygrecka M, et al: Mast cell chymase: an indispensable instrument in the pathological symphony of idiopathic pulmonary fibrosis? Histol Histopathol 28: 691-699, 2013.
10. Günther A, Korfei M, Mahavadi P, von der Beck D, Ruppert C and Markart P: Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis. Eur Respir Rev 21: 152-160, 2012.
11. Coward WR, Saini G and Jenkins G: The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 4: 367-388, 2010.
12. Wynn TA: Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350, 2011.
13. Shimizu Y, Dobashi K, Iizuka K, et al: Contribution of small GTPase Rho and its target protein rock in a murine model of lung fibrosis. Am J Respir Crit Care Med 163: 210-217, 2001.
14. Nagatoya K, Moriyama T, Kawada N, et al: Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 61: 1684-1695, 2002.
15. Murata T, Arii S, Mori A and Imamura M: Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res 114: 64-71, 2003.
16. Mack CP, Somlyo AV, Hautmann M, Somlyo AP and Owens GK: Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem 276: 341-347, 2001.
17. Zhu J, Nguyen D, Ouyang H, Zhang XH, Chen XM and Zhang K: Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19. Int J Ophthalmol 6: 8-14, 2013.
18. Zhou G, Li C and Cai L: Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 165: 2033-2043, 2004.
19. Chen S, Crawford M, Day RM, et al: RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J Biol Chem 281: 1765-1770, 2006.
20. Itoh Y, Kimoto K, Imaizumi M and Nakatsuka K: Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res 84: 464-472, 2007.